π¬ Current Disease Focus:
Task Progress: 0%
π₯ Active Problem Solvers
0
π Experts collaborating globally
β‘ Current Task Assignment
𧬠Genetic Analysis
π Matching experts to specific tasks
π Resource Allocation by Research Phase:
π Data Analysis
π§ͺ Experimental Design
π¬ Clinical Trials
π Treatment Development
The aim of this study is to evaluate the efficacy and safety of TQB2102 com...
Status
Not Yet Recruiting
Location
Henan cancer hospital
Start Date
2025-09-01
Trial ID
NCT07136974
Treatments Being Tested
This is a multicenter, two-arm, exploratory clinical study designed to eval...
Status
Not Yet Recruiting
Location
The Fourth Hospital of Hebei Medical University
Start Date
2026-05
Trial ID
NCT07528898
Treatments Being Tested
HR+/HER2+ breast cancer belongs to a special type of tumor with dual-channe...
Status
Not Yet Recruiting
Location
Multiple Locations
Start Date
2025-12-20
Trial ID
NCT07300215
Treatments Being Tested
At present, the incidence rate of breast cancer has exceeded that of lung c...
Status
Recruiting
Location
Henan cancer hospital
Start Date
2023-05-03
Trial ID
NCT05918328
Treatments Being Tested
The study is being conducted to assess the efficacy and safety of anthracyc...
Status
Unknown
Location
Breast Oncology, Tianjin Medical University Cancer Institute and Hospital
Start Date
2022-10-08
Trial ID
NCT05871918
Treatments Being Tested
This is a randomized, open, positive drug control, multi center phase III s...
Status
Recruiting
Location
The First Affiliated Hospital of Bengbu Medical University
Start Date
2025-09-15
Trial ID
NCT07043725
This is a multicenter, open label, non-inferiority, randomized controlled c...
Status
Recruiting
Location
Sunyat-sen Memorial Hospital
Start Date
2021-12-20
Trial ID
NCT05159193
This is a randomized, open label Phase II-III neoadjuvant study comparing t...
Status
Active Not Recruiting
Location
Shengjing Hospital affiliated to China Medical University
Start Date
2022-05-23
Trial ID
NCT05426486
Treatments Being Tested
Due to neoadjuvant therapy with trastuzumab and pertuzumab is less effectiv...
Status
Unknown
Location
the First Affiliated Hospital of Nanjing Medical University
Start Date
2023-04-15
Trial ID
NCT05430347
Treatments Being Tested
This is a prospective, multi-center, single-arm, phase 2 exploratory study ...
Status
Not Yet Recruiting
Location
Multiple Locations
Start Date
2026-05-31
Trial ID
NCT07589699
Treatments Being Tested